Stroke is the second leading cause of death and disability in the world. 1-2 75% of all stroke deaths and 81% of the total Disability-adjusted life-years (DALYs) lost because of stroke occur in developing countries. 1-2 Given the high recurrence rate, secondary prevention of future stroke among the survivors is pivotal in reducing disease burden. International guidelines recommend that antiplatelet agents are the standard treatment for patients with non-cardioembolic ischemic stroke.
Let’s hear the expert opinions on the role of anti-platelets in the management of stroke. Sanofi and Docplexus have organized an interactive webinar on 7 th February 2020 from 02:00 pm onwards. In this webinar, Dr. Shirish Valsangkar will talk about "Role Of Anti-Platelets In The Management Of Stroke." We invite you to submit your questions, which will be answered by the speaker at the end of the…
